剖宫产后试产、剖宫产后阴道分娩与子宫破裂风险:专家综述
本专家综述讨论剖宫产后试产的决策复杂性,指出子宫破裂是最令人担忧的并发症,虽绝对风险低但与多种临床、既往史、产科及产时因素相关。作者建议在具备医院安全方案(密切监护、避免前列腺素、谨慎滴定缩宫素)的条件下,对多数有1次低位横切口、低位纵切口或不明切口者提供试产,未来研究应聚焦真正危险因素与产时管理。
要点
- 剖宫产后试产决策需结合患者意愿、剖宫产后阴道分娩成功可能性、风险获益评估及分娩中心资源。
- 子宫破裂虽绝对风险低,但可致严重母儿并发症,临床医生应识别相关危险因素以选择合适候选者。
- 对有剖宫产史者行引产或加强宫缩需谨慎;在具备安全方案时,多数单次低位横/纵或不明切口者可提供试产。
核心结论
- 在建立医院安全方案(密切母胎监护、避免前列腺素、需要引产时谨慎滴定缩宫素)的前提下,自发和引产的剖宫产后试产是安全的,应在适当评估、咨询、计划和共享决策后提供给多数有1次低位横切口、低位纵切口或不明子宫切口的患者。
研究设计与样本
- 本文为专家综述,检索范围原文未报告。
主要发现
- 子宫破裂是剖宫产后试产最令人担忧的并发症,可导致严重的母儿患病和死亡。
- 子宫破裂的绝对风险低,但多种临床、既往史、产科及产时因素与风险增加相关。
- 对有剖宫产史的患者考虑引产和加强宫缩时应谨慎。
关键数值与推荐
- 原文未报告具体的危险因素数值、比例或阈值。
临床怎么用
- 临床医生在剖宫产后试产期间应了解相关危险因素,以适当选择候选者并最大化安全与获益、最小化风险。
- 医院安全方案应包括密切母胎监护、避免前列腺素,以及在需要引产时谨慎滴定缩宫素。
- 自发和引产的剖宫产后试产应在适当评估、咨询、计划和共享决策后提供给多数有1次低位横切口、低位纵切口或不明子宫切口的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The decision to pursue a trial of labor after cesarean delivery is complex and depends on patient preference, the likelihood of successful vaginal birth after cesarean delivery, assessment of the risks vs benefits of trial of labor after cesarean delivery, and available resources to support safe trial of labor after cesarean delivery at the planned birthing center. The most feared complication of trial of labor after cesarean delivery is uterine rupture, which can have catastrophic consequences, including substantial maternal and perinatal morbidity and mortality. Although the absolute risk of uterine rupture is low, several clinical, historical, obstetrical, and intrapartum factors have been associated with increased risk. It is therefore critical for clinicians managing patients during trial of labor after cesarean delivery to be aware of these risk factors to appropriately select candidates for trial of labor after cesarean delivery and maximize the safety and benefits while minimizing the risks. Caution is advised when considering labor augmentation and induction in patients with a previous cesarean delivery. With established hospital safety protocols that dictate close maternal and fetal monitoring, avoidance of prostaglandins, and careful titration of oxytocin infusion when induction agents are needed, spontaneous and induced trial of labor after cesarean delivery are safe and should be offered to most patients with 1 previous low transverse, low vertical, or unknown uterine incision after appropriate evaluation, counseling, planning, and shared decision-making. Future research should focus on clarifying true risk factors and identifying the optimal approach to intrapartum and induction management, tools for antenatal prediction, and strategies for prevention of uterine rupture during trial of labor after cesarean delivery. A better understanding will facilitate patient counseling, support efforts to improve trial of labor after cesarean delivery and vaginal birth after cesarean delivery rates, and reduce the morbidity and mortality associated with uterine rupture during trial of labor after cesarean delivery.
引用
- Deshmukh U, Denoble AE, Son M, et al. Trial of labor after cesarean, vaginal birth after cesarean, and the risk of uterine rupture: an expert review. Am J Obstet Gynecol. 2023. PMID: 38462257. doi:10.1016/j.ajog.2022.10.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。